allocetra-ots
Cell therapyexperimental
Clinical trial activity
13 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
10
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started Jan 27, 2019 (NCT03925857)
Timeline
Indications
Studied for
- Arthritis, Psoriatic · Phase 1
- Cholangitis · Phase 2
- Cholecystitis, Acute · Phase 2
- Community-Acquired Infections · Phase 2
- COVID-19 · Phase 2
- Hamartoma · Phase 1/Phase 2
- Intraabdominal Infections · Phase 2
- Neoplasms · Phase 1/Phase 2
- Organ Dysfunction Scores · Phase 2
- Osteoarthritis · Phase 1/Phase 2
- Osteoarthritis, Knee · Phase 1/Phase 2
- Peritoneal Neoplasms · Phase 1/Phase 2
- Sepsis · Phase 2
- Urinary Tract Infections · Phase 2
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06748651 | Phase 1 | Dec 15, 2024 | Tel Aviv University |
| NCT06522035 | Phase 1 | Aug 31, 2024 | Enlivex Therapeutics Ltd. |
| NCT06459063 | Phase 1/Phase 2 (Phase 2) | Jun 10, 2024 | Hebrew University |
| NCT06233474 | Phase 1/Phase 2 (Phase 2) | Jan 26, 2024 | Enlivex Therapeutics Ltd., Nordic Bioscience |
| NCT06208241 | Early Phase 1 (Phase 1) | Jul 12, 2023 | Enlivex Therapeutics Ltd., Hebrew University |
| NCT05581719 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2022 | Enlivex Therapeutics Ltd., Tel Aviv University |
| NCT05431907 | Phase 1/Phase 2 (Phase 2) | Jun 29, 2022 | Enlivex Therapeutics Ltd., Sheba Medical Center |
| NCT04922957 | Phase 2 | Sep 30, 2021 | Enlivex Therapeutics Ltd. |
| NCT04659304 | Phase 1 | Mar 31, 2021 | Enlivex Therapeutics Ltd. |
| NCT04612413 | Phase 2 | Nov 15, 2020 | Cato Research, Clalit Health Services, Enlivex Therapeutics Ltd. |
| NCT04590053 | Phase 2 | Oct 20, 2020 | Barzilai Medical Center, Hebrew University, Tel Aviv University |
| NCT04513470 | Phase 1 | Aug 1, 2020 | Hebrew University |
| NCT03925857 | Phase 1 | Jan 27, 2019 | Enlivex Therapeutics Ltd. |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | For profit | 9 | 8 | 2 | 2019 |
| Hebrew University | Academic/Hospital | 4 | 4 | 2 | 2020 |
| Tel Aviv University | Academic/Hospital | 3 | 1 | 2 | 2020 |
| Barzilai Medical Center | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Cato Research | For profit | 1 | 0 | 1 | 2020 |
| Clalit Health Services | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Nordic Bioscience | For profit | 1 | 0 | 1 | 2024 |
| Sheba Medical Center | Academic/Hospital | 1 | 0 | 1 | 2022 |
8 organizations
Page 1 / 1